SMO and skin basal cell carcinoma: Furthermore, GLI transcriptional activity is upregulated by Serum response factor (SRF) and Megakaryoblastic leukemia 1 (MKL1) in SMO inhibitor resistant BCC ([58] and will be discussed below).